Clinical Trial Update: Safety and Efficacy With NOVOCART® Disc Plus (ADCT) for the Treatment of Degenerative Disc Disease in Lumbar Spine [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluating safety and efficacy of NOVOCART Disc Plus (ADCT) for degenerative disc disease of the lumbar spine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease
• Intervertebral Disc Degeneration
• Intervertebral Disc Displacement

Drugs mentioned

• NOVOCART Disc Plus (ADCT)

Snippet

Sponsor: Tetec AG | Conditions: Intervertebral Disc Displacement, Intervertebral Disc Degeneration | Phase 1, Phase 2 | Status: COMPLETED